Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm.
The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.
Vendor Centerline Biomedical recently initiated the action, removing certain IOPS (Intra-Operative Positioning System) Guidewires, used in vascular procedures, from the market.
Founded in 2019 and based in Chicago, the vendor offers a “leading” infrastructure platform for building, refining and deploying large-scale AI models in medical imaging.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.